Brain cancer survivor Mike Schuster celebrates a milestone he never thought possible.
OMRF discovers compound that could fight deadly cancer
Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
Q BioMed Inc. finalizes license agreement with OMRF, RGCB
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
Love and other drugs
Brain scans of people who are in love look similar to scans of drug addicts.
Research brings new view of difficult urinary disorder
Contrast MRI may lead to better diagnosis for bladder pain syndrome